Martin Rempfer

Title: Martin Rempfer: Innovator in Blood Treatment Technologies

Introduction

Martin Rempfer is a notable inventor based in Gomaringen, Germany. He has made significant contributions to the field of medical technology, particularly in blood treatment devices. With a total of 5 patents to his name, his work focuses on improving patient care through innovative solutions.

Latest Patents

One of Martin Rempfer's latest patents is a blood treatment device comprising alkaline phosphatase. This invention is designed to dephosphorylate extracellular adenosine triphosphate (ATP), adenosine diphosphate (ADP), adenosine monophosphate (AMP), and/or lipopolysaccharide (LPS) in the blood of patients. The device operates within an extracorporeal blood circuit and features a matrix with alkaline phosphatase immobilized on it. This technology is particularly relevant for treating infections, including sepsis and sepsis-associated acute kidney injury (AKI). Another significant patent involves permselective asymmetric membranes, which are suitable for hemodialysis, hemodiafiltration, or hemofiltration of blood. This invention also includes a process for producing these membranes and devices that incorporate them.

Career Highlights

Throughout his career, Martin Rempfer has worked with prominent companies in the medical field, including Gambro Lundia AB and Gambro Lunia AB. His experience in these organizations has contributed to his expertise in developing advanced medical devices.

Collaborations

Martin has collaborated with notable professionals in his field, including Markus Storr and Ralf Flieg. These partnerships have likely enhanced his innovative capabilities and contributed to the success of his inventions.

Conclusion

Martin Rempfer is a distinguished inventor whose work in blood treatment technologies has the potential to significantly impact patient care. His innovative patents and collaborations reflect his commitment to advancing medical science.